February 4, 2021

Pharmaceutical giant Johnson & Johnson on Thursday applied for emergency permission of its one-dose COVID-19 vaccine

The business’s shot is 66 percent effectiv e against moderate to extreme cases of the lethal global pandemic, but it only needs a single dosage and uses strong protection against hospitalization and death from the bug, Politico reported

The J&J vaccine would include a crucial third alternative– in addition to Pfizer and Moderna shots– as the United States struggles to distribute vaccines against the coronavirus, which has actually eliminated more than 455,000 Americans, according to Johns Hopkins University, which is tracking the virus.

However, the J&J variation has actually shown less reliable versus a more aggressive strain of the virus found in South Africa, the report said.

That pressure, as well as an alternative determined in the UK, has been identified in the United States.

Nonetheless, the J&J vaccine supplies a 3rd line of defense.

” Upon authorization of our investigational COVID-19 vaccine for emergency use, we are prepared to begin shipping,” Paul Stoffels, the business’s chief scientific officer, said in a declaration. “We are dealing with great seriousness to make our investigational vaccine available to the general public as rapidly as possible.”